Showing results (601-610 of 632) with videos related to
Sort By:
Pageof 64
The New England Journal of Medicine|February 2, 2017
Radiation with or without Antiandrogen Therapy in Recurrent Prostate CancerWilliam U Shipley, Wendy Seiferheld, Himanshu R Lukka, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023
Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized TrialBenjamin Movsas, Joseph P Rodgers, Mohamed A Elshaikh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2020
Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized TrialsWilliam C Jackson, Holly E Hartman, Robert T Dess, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III TrialsAndrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.European Urology|November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized TrialsAmar U Kishan, Fang-I Chu, Christopher R King, et al.International Journal of Radiation Oncology, Biology, Physics|February 9, 2026
Correlation of Biochemical Recurrence with Adverse Late Toxic Events Following Prostate Radiotherapy (COBALT Study): An Individual Patient Data Meta-Analysis of 7 Randomized TrialsJohn Nikitas, Parsa Jamshidian, Alison C Tree, et al.JCO Clinical Cancer Informatics|May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III TrialsMack Roach, Jingbin Zhang, Osama Mohamad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-AnalysisDaniel E Spratt, Shawn Malone, Soumyajit Roy, et al.The Lancet. Oncology|February 2, 2025
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trialsJohn Nikitas, Parsa Jamshidian, Alison C Tree, et al.Research Square|May 3, 2023
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.Pageof 64